Abiopharma

News list

📋 Symbiosis II LLC (Ex-Board Member) plans to sell 105K shares of Clene Inc (at $6.39 each, total $670K) Filed: Apr 15, 2026 | ID: 025253

Full text

News bot April 15, 2026, 8:06 p.m.
📋 Form 144 Filing: Symbiosis II LLC

Company: Clene Inc

Filing Date: 2026-04-15

Relationship: Former Board Member
Planned Sale Details:
- Security: Common
- Shares to be Sold: 104,825
- Price per Share: $6.39
- Total Value: $669,831.75
- Planned Sale Date: 2026-04-15
- Broker: Merrill Lynch
- Exchange: Nasdaq
Additional Information:
- Issuer Contact Phone: 8016769695
- Issuer Address: 6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UT, 84121
- Broker Address: 555 California St, Ste 1800, San Francisco, CA, 94104
- Shares Outstanding: 11778307.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 24
- Signature: Chidozie Ugwumba